Trademark Overview
On Friday, September 13, 2024, a trademark application was filed for CRYPTOMAP with the United States Patent and Trademark Office. The USPTO has given the CRYPTOMAP trademark a serial number of 98748841. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, March 13, 2025. This trademark is owned by Epitopea Inc.. The CRYPTOMAP trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens; pharmaceutical preparations for the prevention or treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic uses; diagnostic reagents; diagnostic and testing preparations for clinical, medical and medical laboratory use; diagnostic test kits for medical purposes; antibodies for medical purposes
Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicals, reagents and substances for medical research; antibodies for scientific purposes; immunoassay reagents; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use; proteins for scientific or research use; nucleotides for scientific and research use
Diagnostic services in the field of oncology and immunology; medical screening services in the field of oncology
Research and development in the fields of medicine, oncology and immunology; scientific research for medical purposes in the field of oncology; biological data mining; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data relating in the fields of oncology and immunology; biomedical research conducted using databases; consultancy, information and advisory services relating to oncology and immunology